More News

23 May 2020 AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly
20 May 2020 Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
19 May 2020 Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases
18 May 2020 OSE Immunotherapeutics Presents CLEC-1, Novel Myeloid Immune Checkpoint Target for Cancer Immunotherapy
16 May 2020 LegoChem Biosciences and Iksuda Enter Licensing Agreement for Antibody Drug Conjugate Program
14 May 2020 Recursion Enters Into Global Licensing Agreement with Takeda to Develop TAK-733 in Hereditary Cancer Syndrome
14 May 2020 Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA...
13 May 2020 Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide
12 May 2020 Neurocrine Biosciences exercises option to license Idorsia's novel treatment for rare pediatric epilepsy
12 May 2020 Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration
08 May 2020 ACADIA Pharmaceuticals and Vanderbilt University Announce Exclusive License Agreement and Research Collaboration
07 May 2020 PTC Therapeutics to Acquire Censa Pharmaceuticals
07 May 2020 Mediolanum Farmaceutici Acquires the French Company ElsaLys Biotech to Develop Next Generation Immuno-oncology Therapies
06 May 2020 BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions
06 May 2020 Magenta Therapeutics and AVROBIO Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies
06 May 2020 Santhera Signs Agreements in Gene Therapy Research for Congenital Muscular Dystrophy with Rutgers University
05 May 2020 Alexion to Acquire Portola
04 May 2020 Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million
04 May 2020 Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
04 May 2020 BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies
29 Apr 2020 resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
27 Apr 2020 Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel AAV Capsids for Genetic Therapies
27 Apr 2020 Merck and Institute for Systems Biology Collaborate to Define Molecular Mechanisms of SARS-CoV-2 Infection and Identify Potential Prognostic Biomarkers
24 Apr 2020 ProThera Biologics and Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins (IAIP)
23 Apr 2020 EpimAb Biotherapeutics and QIMR Berghofer Medical Research Institute Announce Research Collaboration and License Agreement on Novel Bispecific Target Combinations

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top